GlassScriptPhysician profile
Colin Kress
NPI 1760896112
$3,334.71
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $959 · 2020: $260 · 2021: $877 · 2022: $1,239.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,398.84 | 2019-2022 | |
| Nevro Corp. | $1,091.51 | 2019-2022 | |
| Spr Therapeutics, INC | $170.84 | 2021-2022 | |
| Genzyme Corporation | $102.29 | 2020-2022 | |
| Abbott Laboratories | $93.90 | 2020-2021 | |
| Ucb, INC. | $69.75 | 2021 | |
| Pacira Therapeutics, INC. | $69.09 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $66.57 | 2019-2020 | |
| Avanos Medical | $49.93 | 2021 | |
| Sun Pharmaceutical Industries INC. | $29.22 | 2021-2022 | |
| Stimwave Technologies Incorporated | $24.44 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $24.04 | 2021 | |
| Scilex Pharmaceuticals INC. | $23.49 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.74 | 2022 | |
| Janssen Biotech, INC. | $21.64 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $21.28 | 2020 | |
| Pfizer INC. | $17.48 | 2019 | |
| Neuronetics, INC. | $12.86 | 2022 | |
| Biofrontera INC. | $12.41 | 2022 | |
| Strata Skin Sciences, INC. | $12.39 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Kress listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.